132 - Ross O'Neill, PhD & Hubert Lim, PhD - Lenire: The First FDA-Approved Bimodal Tinnitus Treatment

Guests: Ross O'Neill Ph.D (Founding CEO) & Hubert Lim Ph.D (Chief Scientific Officer) of Neuromod Dave is joined by Ross & Hubert to discuss: - The backstory of how Ross & Hubert met and ultimately partnered together on Lenire - Hubert's research and papers he wrote about paired stimulation & Pavlovian conditioning, which included data that identified tongue stimulation combined with sound as a promising direction to pursue - An overview of what exactly tinnitus is and why Lenire presents such a novel approach to treating tinnitus - Other types of synchronous-stimuli approaches that have emerged in other healthcare verticals (i.e. mirror therapy for phantom limb pain) - The challenging process of gaining FDA approval and the clinical trials that were conducted throughout the process - Being featured as the cover story on Nature Communications - The initial roll-out of Lenire, the current state of the provider network, and the real-world data that's being collected and published

Om Podcasten

Discussing the business of hearing healthcare and how hearing professionals can succeed in a rapidly evolving landscape. Guests of the show include experts with backgrounds in Audiology, Public Health, Consumer Audio, and Technology. The goal of Future Ear Radio is to connect the trends converging around our ears. (FuturEar)